<DOC>
	<DOCNO>NCT00912457</DOCNO>
	<brief_summary>The purpose study determine effect anticholinesterase drug donepezil sleep apnea patient . Sleep structure respiratory parameter analyze polysomnography .</brief_summary>
	<brief_title>Donepezil Treatment Sleep Apnea Patients</brief_title>
	<detailed_description>Cholinergic activity also influence upper airway open via central peripheral mechanism . Decreased thalamic pontine cholinergic projection may affect respiratory drive lead central obstructive apnea least certain degenerative conditions.In contrast prolific literature physical surgical treatment sleep apnea dearth effective pharmacological approaches.Most drug previously test purpose act upon monoaminergic adenosinergic system show unsuccessful ambiguous results.A previous study show donepezil treatment improve apnea-hypopnea index oxygen saturation patient Alzheimer 's disease . Treatment also increase REM sleep duration reduce ADAS-cog scores.Based fact hypothesize donepezil treatment may beneficial sleep apnea patient . Intervention : Patients administer donepezil placebo . The study randomize , double-blind placebo-controlled design . Complete polysomnography perform baseline , 28 day drug placebo treatment , 15 day drug placebo washout 28 day CPAP treatment .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>diagnosis obstructive sleep apnea accord American Academy Sleep Medicine criterion body mass index &gt; 40 use psychoactive drug presence neurological , cardiological pulmonary disease</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>sleep apnea</keyword>
	<keyword>donepezil</keyword>
	<keyword>pharmacological</keyword>
	<keyword>cholinergic</keyword>
</DOC>